mTOR inhibitors in MPNST have been shown to suppress expression levels of the following cellular factors that prevent oxidative damage: sterol regulatory element-binding protein (SREBP), glucose-6-phosphate dehydrogenase (G6PD), and GSH [43]. Here, G6PD is linked to malignant peripheral nerve sheath tumor.